About us
KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
KLISBio is significantly contributing to healthcare innovation, disrupting the restorative surgical market in several clinical indications by bringing innovation via a truly versatile biocompatible material, robust scientific and chemical expertise and operational excellence.
Vision & Mission
KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
Our philosophy
KLISBio is significantly contributing to healthcare innovation, disrupting the restorative surgical market in several clinical indications by bringing innovation via a truly versatile biocompatible material, robust scientific and chemical expertise and operational excellence.
Executive Team
Rodrigo
Bianchi
President & Chairman of the Board.
Board member of PE/VC-backed companies. Former President of big US and European medtech listed groups.
Gabriele
Grecchi
Chief Executive Officer, Board Member
MA in International Economics & Finance. MBA at INSEAD
Antonio
Alessandrino
CHIEF TECHNOLOGY OFFICER, Board Member
PHD IN MATERIALS ENGINEERING AT POLITECNICO DI MILANO
Scientific Founders
Antonio
Alessandrino
CHIEF TECHNOLOGY OFFICER, Board Member
PHD IN MATERIALS ENGINEERING AT POLITECNICO DI MILANO
Giuliano
Freddi
CHIEF SCIENTIFIC OFFICER.
BA IN BIOLOGICAL SCIENCES AT UNIVERSITÀ DI MILANO
WORK WITH US
KLISBio highly believes in giving responsibility and having people grow alongside it. Get to know us or come work with us!
